HSBA

949.7

+0.07%↑

BARC

371

+0.79%↑

LLOY

82.66

+0.83%↑

RBS

534.2

+1.17%↑

STAN

1,413.5

+1.73%↑

HSBA

949.7

+0.07%↑

BARC

371

+0.79%↑

LLOY

82.66

+0.83%↑

RBS

534.2

+1.17%↑

STAN

1,413.5

+1.73%↑

HSBA

949.7

+0.07%↑

BARC

371

+0.79%↑

LLOY

82.66

+0.83%↑

RBS

534.2

+1.17%↑

STAN

1,413.5

+1.73%↑

HSBA

949.7

+0.07%↑

BARC

371

+0.79%↑

LLOY

82.66

+0.83%↑

RBS

534.2

+1.17%↑

STAN

1,413.5

+1.73%↑

HSBA

949.7

+0.07%↑

BARC

371

+0.79%↑

LLOY

82.66

+0.83%↑

RBS

534.2

+1.17%↑

STAN

1,413.5

+1.73%↑

Search

ConvaTec Group PLC

Open

BrancheFinanzen

228.2 0.09

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

226.6

Max

229.6

Schlüsselkennzahlen

By Trading Economics

Einkommen

112M

Verkäufe

1.2B

KGV

Branchendurchschnitt

28.85

25.056

EPS

0.08

Dividendenrendite

2.84

Gewinnspanne

9.517

Angestellte

10,000

EBITDA

289M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+37.34% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.84%

3.86%

Nächste Dividendenausschüttung

1. Okt. 2025

Nächstes Ex-Dividendendatum

21. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-295M

4.8B

Vorheriger Eröffnungskurs

228.11

Vorheriger Schlusskurs

228.2

Nachrichtenstimmung

By Acuity

50%

50%

217 / 535 Ranking in Finance

ConvaTec Group PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Feb. 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Peer-Vergleich

Kursveränderung

ConvaTec Group PLC Prognose

Kursziel

By TipRanks

37.34% Vorteil

12-Monats-Prognose

Durchschnitt 314.5 GBX  37.34%

Hoch 375 GBX

Tief 277 GBX

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ConvaTec Group PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

15 ratings

12

Buy

3

Halten

0

Sell

Stimmung

By Acuity

217 / 535 Ranking in Finanzen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.